{
    "nct_id": "NCT04909138",
    "official_title": "Intermittent Dosing of Dorsal Root Ganglion Stimulation As an Alternate Paradigm to Continuous Low-Frequency Therapy",
    "inclusion_criteria": "* Age between 18 and 99\n* 1-year or more use of continuous DRG therapy as delivered a permanently implanted Abbott PROCLAIM XR Dorsal Root Ganglion Neurostimulator System for chronic back and/or leg pain\n* Endorse at least 50% pain relief in the targeted area over the last year\n* Must have been seen for routine follow-up within last 4 months\n* Must have been reprogrammed in standard fashion at least once prior to randomization\n* Willing and able to complete protocol requirements, including:\n\n  * Complete health questionnaires and pain scales as specified in the protocol\n  * Sign the study-specific informed consent form\n  * Complete follow-ups at the designated time periods\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 90 Years",
    "exclusion_criteria": "* Significant lead migration, as determined by clinician\n* Other concurrent neuromodulation system in place\n* Corticosteroid injection in previous 30 days prior to enrollment\n* Intermittent dosing and/or failure within last 6m\n* Changing or unstable pain medications within 30 days",
    "miscellaneous_criteria": ""
}